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Assessing the prevalence of the Metabolic Syndrome
according to NCEP ATP III in Germany: feasibility and
quality aspects of a two step approach in 1550 randomly
selected primary health care practices
Bestimmung der Prävalenz des Metabolischen Syndroms nach NCEP
ATP III in Deutschland: kleine Machbarkeit und Qualitätsaspekte eines
zweistufigen Erhebungsansatzes in 1550 zufällig ausgewählten
hausärztlichen Praxen
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Objective: Metabolic Syndrome (MetSyn) describes a cluster of meta-
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persons aged ≥18 years attending a general practitioner in Germany.
Here we describe in detail the methods used and the feasibility of de-
termining the MetSyn in a primary health care setting. 1 Institute for Medical
Informatics, Biometry and Researchdesignandmethods:TheGerman-widecross-sectionalstudy
wasperformedduringtwoweeksinOctober2005.Bloodsampleswere Epidemiology, University
analyzedinacentrallaboratory.Waistcircumferenceandbloodpressure Hospital, University of
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were assessed, data on smoking, life style, fasting status, socio-demo-
graphic characteristics and core information from non-participants col-
lected. Quality control procedures included telephone-monitoring and 2 CAREM GmbH, Sauerlach,
Germany random on-site visits. In order to achieve a maximal number of fasting
blood samples with a minimal need for follow-up appointments a step- 3 AlfriedKruppvonBohlenund
HalbachFoundation,Institute wise approach was developed. Basic descriptive statistics were calcu-
lated, the Taylor expansion method used to estimate standard errors
neededforcalculationofconfidenceintervalsforclusteredobservations.
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Results: In total, 1511 randomly selected general practices from 397
out of 438 German cities and administrative districts enrolled 35,869
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patients (age range: 18-99, women 61.1%). More than 50,000 blood
samples were taken. Fasting blood samples were available for 49% of
theparticipants.Oftheparticipatingpatients99.3%returnedquestion-
naires to the GP, only 12% were not filled out completely. The overall
prevalence of the MetSyn (NCEP/ATP III 2001) was found to be 19.8%,
withmenshowinghigherprevalenceratesthanwomen(22.7%respect-
ive 18.0%).
Conclusions: This study was designed to provide data as robust as
possiblewithintheconfinesofanepidemiologicalstudy.Judgingbythe
low degree of missing data and the high data quality, the feasibility for
this kind of a research setting (short evaluation period, practitioners as
data assessment sites) was found to be very good. The results will help
to gain a more comprehensive insight into the prevalence of MetSyn
for patients in primary health care in Germany.
Keywords: Metabolic Syndrome X, primary health care, cross-sectional
study, prevalence study, family practice, Germany
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Research Article OPEN ACCESSZusammenfassung
Hintergrund: Das Metabolische Syndrom (MetSyn) umschreibt einen
heterogenenSymptomenkomplex-Hyperglykämie,Hypertonie,reduzier-
tesHDL-Cholesterin,HypertriglyceridämiesowieabdominelleAdipositas
– der mit einem erhöhten Risiko für kardiovaskuläre Morbidität und
Mortalitätassoziiertwird.EpidemischeZunahmendesSyndromswerden
ausdenUSA undanderenLändernberichtet. Auch in Deutschlandwird
von einer starken Ausbreitung des Syndroms ausgegangen, allerdings
fehlen hier genaue epidemiologische Daten. Ziel der Studie ist eine
bundesweite Querschnittserhebung der Prävalenz des MetSyn gemäß
NCEP ATP III (National Cholesterol Education Program Adult Treatment
Panel III)-Kriterien bei Frauen und Männern ab 18 Jahren in allgemein-
ärztlichen Praxen. Schwerpunkt dieses Beitrages ist die Beschreibung
methodischerAspekte,insbesonderehinsichtlichMachbarkeitinhaus-
ärztlichen Praxen, Verfahren zur Nüchternbestimmung und Qualitätsa-
spekten.
Methoden: Die deutschlandweite, versorgungsepidemiologische
Prävalenzstudie wurde in zwei Wochen im Oktober 2005 bei einer Zu-
fallsstichprobevonhausärztlichenPraxendurchgeführt.Erfasstwurden
BMI, Taillenumfang, Blutdruck, Blutzuckerschnelltest (finger prick),
Serumglukose und -lipide sowie Angaben zu Lebensstil, Vorerkrankun-
gen,Familienanamnese,Medikation,soziodemografischenMerkmalen.
MinimalinformationenvonNichtteilnehmernwurdenerhoben.Qualitäts-
kontrollen umfassten Telefonmonitoring sowie Onsite visits. Ein spezi-
ellesVerfahrenminimiertedieZahlderWiedereinbestellungenaufgrund
von Nüchternbestimmungen. Deskriptive Statistiken wurden mit SAS
9.2 erstellt, die Taylor Methode zur Schätzung des Standardfehlers zur
Kalkulation von Konfidenzintervallen für geclusterte Beobachtungen
angewendet.
Ergebnisse: Insgesamt wurden bei 1511 Allgemeinarztpraxen in 397
von 438 Landkreisen und kreisfreien Städten 35.869 Patienten einge-
schlossen (Altersrange: 18-99, Frauen: 61.1%). Mehr als 50.000 Blut-
proben wurden analysiert, davon 49% als Nüchternbestimmung. Die
Gesamtprävalenz des MetSyn liegt bei 19.8%, Männer weisen höhere
Prävalenzen auf als Frauen (22.7% respektive 18.0%).
Schlussfolgerung:MitderStudiekönnenerstmalsbundesweiteZahlen
zur Prävalenz des Metabolischen Syndrom nach der genauen NCEP
ATP III–Definition vorgelegt werden. Die Qualität der erhobenen Daten
überstiegdieErwartungen.Derstepwiseapproachführtezueinerhohen
Wiedereinbestellungsquote.Soweiteinschätzbarkonntensystematische
FehlerquellenmittelsdesrobustenStudiendesignsinGrenzengehalten
werden.InsgesamterweiterndieDatendieserStudiedenWissensstand
in Deutschland um das Metabolische Syndrom und dessen konstituie-
rendenEinzelfaktoreninhausärztlichenPraxen.NachfolgendeAnalysen
ermöglichen Prävalenzbestimmungen auch nach den neueren Defini-
tionen des Metabolischen Syndroms.
Introduction
Metabolic Syndrome (MetSyn), also known as insulin
resistance syndrome, Syndrome X or Deadly Quartet,
describesacombinationofmetabolicdisordersthathave
been found to be associated with an increased risk of
cardiovascular disease (CVD), and overall mortality [1],
[2], [3], [4]. Several different definitions for MetSyn are
inuse[5],allinvolvingincreasedbloodpressure,abdom-
inal obesity, increased serum triglycerides and lowered
HDLcholesterolasmajorparameters.Differencesamong
the definitions include the valuation of hyperglycemia,
insulin resistance or glucose intolerance. Currently the
most accepted definitions are those of the World Health
Organization (WHO) [6], the National Cholesterol Educa-
tion Program Adult Treatment Panel III (NCEP ATP III) [7],
and the recently modified definitions by the American
Heart Association (AHA)/National Heart, Lung and Blood
Institute (NHLBI) [8], [9] and the International Diabetes
Federation (IDF) [10], with the main difference being
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the WHO definition but not in the NCEP ATP III-
/AHA/NHLBI-definition, as well as different cut points of
dichotomizedriskfactors,inclusionofdrugtreatmentfor
hypertension and triglyceridemia, and central obesity as
a necessary requirementfor the diagnosisof the MetSyn
[10]. However, since no insulin levels have to be determ-
ined when using the NCEP ATP III, AHA/NHLBI-definition
fordiagnosis,thisapproachiseasiertoapplyforepidemi-
ologicalstudiesaswellasinprimaryhealthcarepractices
and is therefore the most widely used.
MetSyn is common in persons with abdominal obesity,
and it is considered an independent risk factor for CVD
[11]. However, this is not without controversy. Since only
3 out of 5 criteria have to be met for MetSyn diagnosis
according to NCEP guidelines, there are 16 different
conceivable combinations of risk factors that cannot be
weighted equally in terms of predictive importance for
CVD [12]. It has even been reported that the excess risk
of CVD in patients with MetSyn is only due to diabetes
and is independent from all other criteria. [13]. What is
known for sure is that the cardiovascular risk increases
disproportionately with coexistent arterial hypertension
[14].
Epidemiologic studies have shown that the prevalence
of MetSyn varies depending on the different definitions
of WHO and NCEP [15]. Although there is no consistent
information, combined data from Germany, the USA and
Finland give a rough estimate of MetSyn prevalence in
the range of 10%-25% among 35-70 year olds [16], with
a higher frequency in men than women. First indications
on the MetSyn prevalence in Germany result from an
analysisapproachingtheNCEPdefinition[17].Neverthe-
less, detailed information about the MetSyn in Germany
is limited.
The objective of our study was to assess the MetSyn
prevalenceaccordingtotheNCEPATPIII-definition(2001)
in a primary health care setting in Germany during a 2
week assessment period. All patients ≥18 years of age
attending their primary health care physician for general
health issues at randomly selected sites were examined
in the course of a single morning on all 5 criteria of the
MetSyn. In order to achieve a maximal number of fasting
bloodsampleswithaminimalneedforfollow-upappoint-
ments a stepwise approach was developed.
Since this study was conducted in October 2005, the
study protocol and study material had to be finished in
the beginning of 2005, half a year before the release of
the IDF- and updated AHA/NHLBI-definitions. For this
reason the most widely used NCEP ATP III-definition was
chosenheretoestimatetheMetSynasprimary outcome
variable.Neverthelessinsecondaryanalysisitisplanned
to calculate and compare the different definitions pub-
lished recently.
The purpose of this paper is to describe in detail the
methods used and evaluate the feasibility of screening
patients in primary health care settings when patients
visited for routine care, particularly with regard to prob-
lems of achieving fasting blood samples, the very short
evaluation period, missing data and data quality.
Methods
Study design and participating
physicians
Weconducteda2-weekcross-sectionalprevalencestudy.
Generalpractitionersandinternistswithfocusonprimary
health care (both henceforth abbreviated as GP) were
selected by a stratified, randomized sampling method to
receive a randomdistributionacrossallGermanregions.
Medical practices specialized in cardiology and/or dia-
betes were excluded from the study.
Physicians were contacted once by mail and informed
about the background and aims of the study. They were
asked to complete a fax questionnaire indicating their
consent to participate in the study (or to give a reason
for non-participation). The fax response further included
site information about personal data, specialization of
the GP as well as equipment of the site, especially with
respecttothesurveyrequirements.Incaseofnon-contact
ornon-response,nofurtherrecruitmenteffortwasmade.
Study population
The study population comprised all male and female pa-
tients ≥18 years of age who visited their GP at the par-
ticipatingsitesonthedayofthesurvey(regardlessofthe
reason for visiting) and who gave their written informed
consent for participation. The only reasons for exclusion
were conditions that made it impossible or highly prob-
lematic for the patient to participate (such as poor Ger-
man language skills, serious disabilities or diseases),
acute emergencies, or pregnancies and breast-feeding
within the previous 3 months. The study protocol did not
allow for further selection of patients.
All patients who were eligible on the given day were in-
cluded consecutively. At each site, the participating GPs
andtheirstaffassessedtheindividualcriteriaforMetSyn
andbasicdataonsocio-demography,anamnesisandlife
style in the course of a single morning (except for the re-
cruitment group “young”, for which the survey was
extendedtoawholeday,seebelow)usingquestionnaires,
materials and procedures provided for the study.
Non-response
To rule out that non-response resulted in a biased
sampling of participants, age group (<45 years, 45-59
years and ≥60 years of age), sex, reason for attendance
of the medical practice, obesity (as judged by the physi-
cian or the nurse), risk of coronary heart disease (as
judgedbythephysicianorthenurse),andreasonfornon-
responseinthestudyweredocumentedforpatientswho
did not give their informed consent for participation.
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Since food intake has an impact on serum glucose and
triglyceride levels, which are important criteria in deter-
mining MetSyn, a two-stage approach was applied for
blood sampling. First, all patients on the predetermined
examination day were included regardless of fasting
status. By using a blood glucose (BG) quick test, it was
possible to directly exclude or diagnose hyperglycemia,
independent of the patient’s fasting state, based on the
selected capillary BG concentration cut points of <5.56
or >11.11 mmol/L. If the findings concerning fasting
serum glucose or triglycerides were ambiguous due to a
meal in the previous 8 respective 12 hours, the patient
was asked to come for a second appointment to give a
fasting blood sample. Furthermore, a random sample
(30%) of participants was asked to come for a second
fasting blood sample, regardless of the first test result
(see below Sampling strata for recruitment of study par-
ticipants). These data provided useful information about
intra-individual variations, e.g. regression-to-the-mean
effects.
Ethical approval
Ethical approval was granted from the ethics committee
of the University Hospital, University Duisburg-Essen, Es-
sen, Germany.
Pre-study
Due to the complexity of the survey and for sample size
calculation purposes, a pre-study was performed. The
pre-studyalreadyusedallcomponentsofthemainstudy,
including the clinical research organization (CRO), the
centrallaboratory,siterecruitmentandpatientsampling.
The survey instruments included the questionnaires and
laboratory analyses.
Information was collected on the following in the pre-
study:
• Response rate and participation of GPs
• Quality of information material for GPs and their em-
ployees
• Recruitment of patients
• Time frame for examinations
• Quality of questionnaires in terms of completing
validity and understanding
• Logistic courses/communicational structures (espe-
cially laboratory logistics).
Timeline
A pre-study was conducted in June 2005 and the main
studyfollowedinOctober2005.Thesecondreferralsand
return of completed questionnaires were finished on
December 2
nd 2005, and double data entry was finished
by the end of December 2005. Data quality checks and
the creation of a scientific database were completed by
the end of March 2006.
Sample size calculation
Calculations for determination of the study population
size were based on basic assumptions (as outlined be-
low), on results and experiences of the pre-study, and on
the strategy of recruitment. The sample size calculation
was aimed to get even numbers of patients in six strata
defined by sex and age group (<45 years, 45-59 years
and ≥60 years of age).
Basic assumptions
Calculations of the number of patients to be included
were based on the following data and assumptions:
• In the expected range of prevalence p per age group
and sex a precision of 100•d = 2% was to be accom-
plished, with d = 1.96•(p•(1-p)/n)
½ being the half-
width of the 95% confidence interval of the binominal
distribution of the prevalence p at samples size n.
• The distribution of age and sex in a random sampling
atparticipatingsitesweregatheredfromthepre-study.
• The drop-out rate of recruited patients due to incom-
plete or implausible statements was estimated to be
20%.
Consideration of pre-study results
• Number of participants and valid observations with
respect to MetSyn
In the pre-study, the survey was conducted at 25 par-
ticipating sites. From 772 patients whose age and sex
were specified, 619 patients met all inclusion criteria
and participated in the study. A total of 497 patients
could be evaluated regarding MetSyn, and for 362
patientsall5criteriaoftheMetSyncouldbeevaluated
(for evaluation, 3-4 criteria are sufficient if at least 3
criteria are positive or 3 criteria are negative). There-
fore,thestudyyieldedanaverageof24.8participating
patients per site, and an average of 19.9 patients per
site could be assessed with respect to MetSyn. The
numberofpatientswasdifferentintheseparatestrata
defined by age and gender. Both men and women 60
years and older were enrolled more often than men
and women of younger age groups: for those ≥60
years, 108 men and 140 women could be assessed,
but only 36 men and 86 women <45 years, and 50
men and 77 women in the age group of 45-59 years.
This information helped to optimize the recruitment
strategy in the main study with respect to age groups.
• Effects of monitoring
In the pre-study, 18 out of 25 participating sites were
attended by specifically trained monitors, the other 7
sites were not monitored. On average, fewer par-
ticipants (17% less) were recruited at sites without
monitoring. However, due to the smallnumberof sites
and a high variation in the number of patients docu-
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in either direction are difficult to interpret. In the main
study about 10% of the sites were attended by moni-
tors. Therefore, it was expected that the average
number of participating patients per site in the main
study would be approximately 15% less than in the
pre-study. This overall average included the assump-
tion that some sites would fail to participate at all.
Given these considerations and the recruitment group
design described below, a total of 35,000 participants
were to be enrolled at 1660 sites in the 2-week period.
In this way an even distribution of patients were to be
achieved in three age strata, and the estimated preva-
lence for age group and gender would have the desired
precision (95% confidence interval width of ±2% or
smaller) in each stratum.
Sampling strata
Sampling strata for recruitment of medical
health care sites
Consideringanestimatedresponserateof10%,approxi-
mately 17,000 sites had to be contacted and asked for
participation in order to obtain the targeted number of
sites and patients. A regionally stratified random sample
of addresses was provided by Schwarzeck Verlag (Otto-
brun, Germany).
The number of GPs in each stratum (10 postal regions
identified by the first digit of the postalcode) was propor-
tionaltothenumberintheaddressbase.Inthepre-study,
physicians’ response and participation were not system-
aticallyrelatedtoregion,ageorsex,andthereforepoten-
tial non-response bias appeared to be unlikely.
Sampling strata for recruitment of study
participants
To perform an optimal recruitment strategy, 3 sampling
strata or recruitment groups were created:
1. Recruitment group 1: normal
All participatingpatientsin this group were examined
and asked for a blood sample. In case the findings
for fasting serum glucose or fasting serum trigly-
cerideswereambiguousduetoamealintheprevious
8 hours (serum glucose) or 12 hours (serum trigly-
cerides), the patient was asked to come for a second
appointment to give a fasting blood sample, possibly
within the following 2 weeks.
2. Recruitment group 2: sample
Patients in this group were asked to give a second
fasting blood sample within the following days, inde-
pendent of their fasting state and findings from the
blood sample on the day of the survey. Data of pa-
tients in this group who gave fasting blood samples
atbothvisitsareusedtoestimateintra-individualday-
to-dayvariationsoftheBGandtriglycerideconcentra-
tionsaswellastoconfirmtheresultsandconclusions
drawn from the BG quick test and to ensure its
usability.
In the pre-study, only 45% of the patients who had
been asked to give a second blood sample actually
returned for the second appointment. Additionally,
approximately20%ofthedatasetslackedsomedata.
As the goal was to obtain a second blood sample for
3200 participants (approximately 10% of the total
study population), approximately 8800 patients had
to be scheduled for a follow-up appointment (8800 x
45% x 80% = 3200).
3. Recruitment group 3: young
Resultsofthepre-studyhadshownthattheagegroup
of ≥60 years of age was the most represented in the
studypopulation.Theleastrepresentedwasthegroup
ofmen<45yearsofage,followedbymenandwomen
between 45-59 years of age. To ensure an accurate
determination of MetSyn prevalence in the underre-
presented younger age groups, only patients <60
yearsofagewererecruitedinasubsetofparticipating
medical practices. In order to allow for sufficient
numbers of patients in the survey, recruitment was
extended to a whole day for this group.
500 sites were assigned each to the recruitment groups
1 and 2. A total of 21,000 patients were expected to
participate at these 1000 sites. 660 sites were assigned
to the recruitment group 3, with a targeted 14,000 par-
ticipants. GPs were assigned randomly to the 3 recruit-
ment groups. After the study, not all sites submitted data
even after a reminder by mail or phone to submit the
results. This problem had been predicted and included
in the sample size calculation.
Procedure of the survey
Recruitment of GPs:
• Approximately 17,000 sites were selected randomly
and contacted once by mail between August 29 and
September12,2005,tobrieflyinformthemaboutthe
study and request their participation.
• Every participating GP was assigned a survey date.
• 1-2weekspriortobeginofthestudy,participatingGPs
received 2 packages including detailed information
material, questionnaires, documentation forms and
laboratory material.
• AtelephonehotlinewasrunbytheCROandthecentral
laboratory starting from the day of the first mail con-
tact.
5/16 GMS German Medical Science 2006, Vol. 4, ISSN 1612-3174
Moebus et al.: Assessing the prevalence of the Metabolic Syndrome ...• Each participating site was given a “wake-up call” 2-3
days prior to the respective survey day to remind the
GP and his/her employees about the study and the
planned survey day and to acknowledge the receipt of
information and laboratory materials.
Recruitment of study participants:
• According to the assigned recruitment group, each
physicianwastoenrollall consecutivemenandwomen
presenting for routine care regardless of the reason
(prescriptions, check-ups, etc.), either within a single
morning (recruitment groups 1 and 2) or over the
course of an entire day (recruitment group 3). Each
doctor had received questionnaire forms for a
maximum of 50 patients, which seemed sufficient for
most sites (23 out of 25 sites in the pre-study contrib-
uted less than 50 patients). If the number of patients
was less than 50, the doctor was asked to return the
unusedquestionnaireformsalongwiththecompleted
ones.
• Core information for all non-responders was to be
documented on a standardized questionnaire.
• To eliminate or reduce the bias of selecting risk pa-
tients, the physicians should not select patients, but
instead include all patients on an otherwise “normal”
day. The patients learned about the study only after
entering the physician’s practice on the day the study
was conducted.
Follow-up appointment
If a non-fasting BG concentration of 5.56-11.11 mmol/L
oranon-fastingbloodtriglycerideconcentrationof≥1.71
mmol/Lofthevenousbloodsamplewasdetermined(see
below), the patient had to be scheduled for a follow-up
appointment to collect a second, fasting venous blood
sample. At the follow-up appointment the patient was
again questioned about the intake of the last meal and
last drink and the blood pressure was measured.
In sites belonging to the recruitment group 2 (“sample”),
all patients were asked to return for a follow-up appoint-
ment for a second, fasting blood sample.
Data collection
Questionnaires
The medicalquestionnaire (examinationform)wasto be
completed by the GP or his/her assistant and the follow-
inginformationaboutthepatientwastobedocumented:
• Age (month and year of birth), sex, reason for attend-
ance of the medical practice (according to question
32D of the Germany Health Survey, [18]), reason for
refusal to participate in the study (if applicable).
• Bloodpressure,bodyweight,bodyheight,waistcircum-
ference, blood sample data.
• Type and time of the last meal and drink.
• Pre-existing cardiovascular diseases (CHD, esp.
myocardialinfarction,anginapectoris,stroke,peripher-
al arterial occlusive disease [pAVK], cardiac insuffi-
ciency).
• History of diabetes (type 1 or 2).
• Other major diseases (hypertension, metabolic dis-
orders,thyroiddisorders,gout,liverdisorders,cancer).
• Medication(antidiabetics,methyldopa,beta-blockers,
diuretics, lipid reducers, corticosteroids, thyroid hor-
mones,highdosageacetylsalicylicacid[>2g/d],high
dosage ascorbic acid [>0.4 g/L], thyrostatics).
The patient questionnaire contained questions concern-
ing
• Age, sex
• Medical history
• Time since last doctor visit, frequency of doctor visits
in the past 4 weeks
• Smoking habit (including former smoking habit and
year of quitting)
• Exercise and physical fitness (according to questions
61, 64 of the BGS98 [18])
• Nutrition (general habits according to abbreviated
question 53, 58 of the BGS98 [18], current and previ-
ous diets, last meal/drink)
• Family anamnesis
• Pregnancy status
• Sociodemography (education,occupationand marital
statusaccordingtotheGermanDemographicStandard
[19]).
The main goal was to obtain the highest possible rate of
completed, high quality forms. The number of questions
was thus reduced to a minimum to minimize the number
of patients who might refuse to participate because they
considered the questionnaires to be too demanding. Ac-
cording to pre-study results, the patients completed the
questionnaires within 5 to 30 minutes, with an average
of 10 minutes.
Blood pressure
Blood pressure was measured in a sitting position after
a 5-minute rest with the equipment commonly available
inthemedicalpractice.Acceptedepidemiologicstandards
for blood pressure measurement (triple measurement,
at least 10 minutes recovery) could not be met in this
case.
Waist circumference
Waist circumference was measured with the provided
common tape measures at the narrowest point between
the last rib and the highest part of the iliac crest. For
obesepatientsthelastribandthehighestpartoftheiliac
crest were palpated manually and measurement was
performed at half distance between both positions.
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An initial screening BG quick test from a capillary (finger
stick) sample was performed with every patient and the
results were documented in the reporting form.
Additionally,foreachpatient,venousbloodsampleswere
collected and shipped within 24 hours to the central
laboratory (Labor 28, Berlin, Germany) by an assigned
courier service . The blood samples were analyzed for
levels of glucose, LDL-cholesterol, HDL-cholesterol, total
cholesterol and triglycerides. GPs were equipped from
the central laboratory with pre-labeled natriumfluorid-
(NaF) and serum tubes for taking the samples.
Blood glucose
NotethatBGdatawerecollectedinmg/dL,butarerepor-
tedhereusingtheSIunitsofmmol/L.Theinitialcapillary
BG quick test was performed to identify all patients with
a BG concentration of <5.56 mmol/L or those with a BG
concentration of ≥11.11 mmol/L. These 2 groups were
not required to be assigned for a second visit. Only BG
levels between 5.56 mmol/L and 11.11 mmol/L did not
allow an immediate assessment of the BG status, so
these patients were scheduled for a follow-up visit within
the following 2 weeks to provide a second, fasting blood
sample. This step-wise approach considerably reduced
theneedforfollow-upappointments.Furthermore,those
subjects requiring a follow-up visit were told that their
findings were ambiguous and that the second blood
sample was necessary to properly assess their medical
condition. The aim was to increase the patients’ motiv-
ation to return for the second appointment and thus to
increase the number of patients with fasting blood
samples.
Triglycerides
Initial blood triglyceride concentrations in the venous
blood samples below 1.71 mmol/L (150 mg/dL) were
considered normal, and fasting values of 1.71 mmol/L
or higher were considered elevated. In both cases, no
furtherbloodsamplewasnecessary.However,initialnon-
fastingvaluesof1.71mmol/Lorhigherrequiredconfirm-
ation from a second fasting blood sample to distinguish
betweenahighlipidconcentrationduetoapreviousmeal
or due to dyslipidemia.
Blood analysis
All samples were analyzed by Labor 28 AG, Berlin, using
Roche Hitachi MODULAR systems.
Plasma glucose levels from blood in the NaF tube were
estimated by the glucose-6-phosphate dehydrogenase
method (G6P-DH).
Triglyceride levels from blood in the serum tube were
estimated by the enzymatic color test. If the level was
>11.43mmol/L(1000mg/dL),theanalysiswasrepeated
with a reduced volume. In both cases, control kits used
were Roche PrecinormU and Precipath P and calibration
was conducted at least 3 times a day. Total cholesterol,
HDL-cholesterol and LDL-cholesterol levels were esti-
mated by enzymatic color tests.
Quality assurance
Guidelines
The study was planned and performed according to the
GermanguidelinesforGoodEpidemiologyPractices(GEP)
andtherespectivestandardoperatingprocedures(SOPs)
of the Institute for Medical Informatics, Biometry and
Epidemiology, as far as the latter were relevant for epi-
demiological studies.
Monitoring concept
To reduce the logistics of coordinating such a large,
country-wide study, participating GPs received no other
instructions than the information material sent to them
by mail prior to the survey. To control for a proper proced-
ure and to ensure the robustness of the data obtained,
a specifically adapted monitoring system was designed
to meet the high logistic needs. This monitoring concept
includedtelephone-monitoringandrandomon-sitevisits.
Themonitorswerespecificallytrainedpriortostartofthe
study, especially in terms of survey procedures in the
different recruitment groups and criteria for follow-up
appointments.
Telephone monitoring
Telephone monitoring was performed at 50% or more of
the enrolled sites prior to the day of the survey to ensure
allparticipatingphysicianshadthecompleteandcorrect
set of forms, documents and blood sampling materials
available on the survey day. Additionally, the knowledge
of the employees concerning the project was checked to
avoidsystematicerrorsthatmighthavehadadirectinflu-
enceontheprimary target value(prevalenceofMetSyn),
e.g. by selective appointment of potential MetSyn risk
patients.Physicians to be includedin telephonemonitor-
ingwereselectedrandomlybutstratifiedbythe3recruit-
ment groups. To guarantee a standardized interview, a
questionnaire with 15 questions was provided. After the
phonecalltheinterviewersratedthemonitoredsitebased
on the interview results.
For rating, particular emphasis was placed on the follow-
ing issues which led to lower ratings:
• Refusal of the telephone monitoring
• Referral of risk patients
• Procedure for follow-up appointment not (correctly)
known
• Usageofthedocumentsveryunclear(atleast2wrong
answers out of 4 questions)
• Inclusion criteria wrong
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On-site visits were performed on the day of the survey,
with a focus on quality of data and measurements.
Monitoring visits were planned in at least 10% of the
participating medical practices. A priori, these practices
were chosen at random though proportional to the 3 re-
cruitment groups. Some sites that received a poor rating
after the telephone monitoring were to be specifically in-
cludedintheon-sitemonitoring,ifpossible.Theobserved
qualityproblemsanderrorsatthemonitoredsitesallowed
an estimation of the overall error rate of the study. For
example, data from sites that did not follow the inclusion
rules could be compared to data from sites where the
instructions were followed precisely to estimate the pos-
sible extent of selection bias.
Major issues of on-site monitoring were:
• Correct completion, signature and dating of the in-
formed consents
• Correct measurement of all parameters
• Inclusion of all eligible patients
• Integrity of the questionnaire data
• Correct follow-up procedures in the different recruit-
ment groups
If possible, 5 questionnaires from the GP as well as 5
questionnaires from patients were to be checked for in-
tegrity. The GP assistants were requested to rectify ob-
served errors. The data base contained a FAQ list that
was continuously updated.
Data entry
Shipment of the questionnaires was organized by the
participating CRO (IFE, Germany, Essen). Data were
entered manually as double entry (using Proc Compare)
from the questionnaire by the CRO. During data entry,
automatic plausibility controls (e.g. range checks) were
conducted. Data handling was specified by the CRO’s
SOPs. The CRO delivered a raw data set including docu-
mentation, that was checked for errors according to pre-
defined plausibility checks.
All data entry forms were checked for plausibility and in-
tegrityaswellasforcompliancewithinclusion-andexclu-
sioncriteria.Alldatasetswerecheckedforincorrectdata
and corrected if applicable; all corrections were docu-
mentedanddoublecheckedbyasecondperson.Alldata
sets were submitted for biostatistic analysis.
Data analysis
Sensitivity analyses and additional quality
measures
The estimates were checked for potential bias by sensi-
tivity analysis. Incomplete data, especially with respect
tothecriteriaofMetSyn,wereanalyzedusingimputation
analysis and a comparison of available case analysis
versus complete case analysis. The effect of the correc-
tions was analyzed by a comparison of raw data versus
corrected data analysis. With respect to fasting time, the
effect of a potential recall bias on the part of the inter-
viewees was analyzed by using different time limits for
fasting status, and also a comparison of fasting data
versus random data. The effect of non-response and
sampling error was analyzed with an age and gender
standardization.
Diagnostic conventions
The criteria for MetSyn were defined in accordance with
NCEPATPIIIconventionsaspublishedin2004(seeTable
1). Diabetes was defined as the patient having diabetes
according to either the current doctor’s diagnosis, or the
patient’s declaration, or the use of diabetes medication.
History of CVD was based on the doctor’s anamnesis.
Additional risk factors like diet, smoking, activity habits
and family history of myocardial infarction and coronary
diseaseweredefinedbasedonthepatient’sself-reported
data in the standardized patient questionnaire.
Statistics
For the main variables of the study, basic descriptive
statistics, number of observations, mean, standard devi-
ation, median (complemented by standard deviation of
the mean, lower and upper quartile as well as 5% and
95%quantiles,minimum,maximum,and95%confidence
interval for the population mean) were calculated.
The sample population (patients) was drawn from
samplingunits(=physicians’practices).Theobservations
were clustered because of similar sites. This had con-
sequencesforstatisticalcalculations,e.g.thecalculation
of confidence intervals. Here we used the Taylor expan-
sion method [20], [21] with the SAS proceduresSURVEY-
FREQ (for tables of frequencies) and SURVEYMEANS (for
means), which is a well accepted method for analysis of
clusteredsamples.Allstatisticalanalyseswereconducted
usingthestatisticalsoftwarepackageSAS9.1(SASInsti-
tute, Cary, NC, USA).
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Results
Participating primary health care
practices
Of the 17, 271 primary health care practices contacted,
2600 responded to the invitation to participate in the
study (15% response). The response rate varied slightly
in the different postal code areas but no differences
greater than +/-2% between contacted and participating
sites for each region could be observed (Table 2). The
first 2070 response faxes were collected and analyzed
foreligibility.Theserevealed1835eligiblephysiciansout
of which the first 1700 were recruited for participation.
Among these, 140 cancelled their participation before
starting the study, mainly due to time-related issues,
communication problems or illness. 33 of the 1835 ori-
ginally eligible physicians were recruited in a second run
to replace cancellations among the 1700. One physician
was found to be on the recruitment list twice. 81 physi-
ciansdidnotreturnthesurveymaterialdespitearemind-
er sent to them by mail, which reduced the final number
of participating sites to 1511.
Monitoring
Telephone monitoring
Outof1046attemptedcalls,913sitescouldbeincluded
in the evaluation of the telephone monitoring. This out-
numbered the targeted 50% of the 1600 sites that had
been aimed for recruitmentby n=124. The interview was
refused at 42 sites, e.g. due to a lack of knowledge on
the topic/absence of the responsible person (12 sites),
lack of time (8 sites) and other, mainly organizational
reasons (such as postponement or cancellation of the
survey day; 11 sites). In 2 sites general disinterest in the
interview was expressed and 3 sites did not consider the
telephone to be a suitable medium of communication.
Most sites were rated 3 or 4 (with 1 being best and 6
being worst) in the telephone monitoring, as shown in
Figure 1. The distribution of ratings was similar in the 3
recruitment groups.
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Figure 1: Rating of sites after telephone monitoring by recruitment group (ohne Markierung)
On-site visits
185 on-site visits were performed out of which 20 were
not successful. 10 sites were visited due to their bad
rating (rating 5 or 6) in the telephone monitoring; 2 of
thesesitesdecidednottoparticipateinthestudyonshort
notice.
In 27 sites not all patients who attended the practice
were included in the study and in 9 cases patients were
not properly informed about the study. Mistakes in the
recruitment strategy were observed in only 3 cases.
Data quality
About 38% of the individuals with casual capillary blood
levels or individuals in recruitment group 2 (“sample”)
did not return for the required fasting blood sample test.
However, among the patients who did return for the fol-
low-up appointment, the percentage of fasting blood
samples (≥12h fasting) increased from 17.0% at the
surveydayto62.7%atthereferral(Figure2).Differences
between individuals who returned for the follow-up ap-
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Figure 3: Number of non-eligible, non-responding and participating patients
pointment and those who did not return will be part of
ongoing analyses.
99.3% of the participating patients returned self-com-
pleted questionnaires to the GP. About 12% were not
filled out completely. 84.1% of patients reported no
problems with the questionnaire, while 10.1% found the
questionnaire difficult to read (they needed glasses),
1.8% said it was difficult to answer some questions, and
7.8% said that another person helped them to complete
the questionnaire (multiple responses possible).
Participating patients
A total of 47,924 patients visited the participating sites
ontherespectivesurveyday.5516ofthesepatientswere
not eligible to participate in the study for several reasons
(Figure 3). Out of the eligible 42,408 patients, 6539
(15.4%)didnotgivetheirinformedconsenttoparticipate
in the study, which resulted in inclusion of 35,869 pa-
tients (85.6% response rate). Incomplete data were col-
lected for 6527 patients.
The gender and age group distribution of patients in the
main study as well as the relative distribution in the pre-
studyisshowninTable3.Therecruitmentprocessoptim-
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Table 4: Prevalence of the Metabolic Syndrome according to NCEP ATP III and AHA/NHLBI1* definitions
ization led to an even distribution in the 3 age groups.
However, the majority of participants (61.1%) were wo-
men.
Table 4 shows the overall and sex- and age-stratified
prevalence of the MetSyn depending on the MetSyn-
definition used. According to the original NCEP ATP III
definition (2001), the prevalence in the study population
was 19.8% (men 22.7%, women 18.0%). Using the
AHA/NHLBI definition from 2004, with a lower threshold
forfastingglucosebeingtheonlychangetotheNCEP/ATP
III 2001 definition, the prevalence was 21.5% (men
25.1%,women19.3%).ThenewestAHA/NHLBIdefinition
from2005resultedinthehighestprevalencewith28.0%
(men 34.3%, women 24.2%). This is because the 2005
definitionincludestreatmentofelevatedlipidsandhyper-
tension,whereasthe2001and2004definitionincluded
diabetes treatment only.
Discussion
Screening for MetSyn was performed in primary health
caresettingwhenpatientsattendedforroutinecare.The
study yielded a high data quality and a large proportion
ofcompletedatasets,especiallyconsideringthefactthat
the survey was performed under normal every day condi-
tions at the medical practices.
In developed countries such as Germany, 90% of the
adult population see their physicians on a regular basis
[22]. Additionally, the primary health care physician can
obtain appropriate consent and easily follow up on the
patient in case of abnormal results.
The pre-study applied in this study enabled an a priori
assessment of some of the potential pitfalls in applying
the survey and in the study strategy. It proved to be a
suitable tool to estimate the response rate of the sites
andenabledanevendistributionofdifferentageclasses
in the main study.
Although the actual number of participating physicians
(1511) in the main study was slightly below the targeted
1600, this was compensated by the high number of
documented patients per site when compared with the
pre-study results. Considering the short survey period,
thesinglecontactforinitialrecruitmentofphysiciansand
thefactthatapproximately700physicianswhogavetheir
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participating sites is to be considered as very high.
Data quality was enhanced by a two-step monitoring
conceptthatimprovedtherecruitmentefficacy(asshown
by the pre-study) and helped to reveal problems and dif-
ficultiesthatcouldberemediedduringthesurveyperiod,
thereby ensuring the integrity of the data sets.
Most questionnaires (88%) were returned completely
filled out. This high percentage was achieved by using
short, standardized questionnaires that could be com-
pleted by the patients in an average of 10 minutes. By
keeping the questionnaires short, all data necessary to
assess the primary target criteria, the MetSyn according
to NCEP ATP-III, could be collected from a large number
of patients in a relatively short time. Overall, a high level
of completeness and comparability was achieved with a
reasonable amount of effort.
MetSyn is diagnosed by evaluation of fasting BG, trigly-
cerides, HDL cholesterol, blood pressure and waist cir-
cumference. The analysis of blood samples was thus an
essential parameter of the survey, and in particular the
considerationofthequalityofmeasurementsmadeunder
non-standardized conditions.
Methods for determination of BG are well established.
However, individual biological and pre-analytical factors
suchasmealintake,bodyconstitutionandactivity,delay
between taking of the blood sample and sample pro-
cessing, centrifugation and stabilizing additives, and
durationandtemperatureofstoragecanhaveanimport-
ant impact on the results [23]. Because the study was
performed in the course of general medical practice
activities, no highly standardized, optimized conditions
suchaskeepingthebloodsamplesat4°Candimmediate
centrifugation [24] could be achieved. It is known that at
room temperature the glucose concentration in venous
blood declines at 0.33 mmol/L per hour, independent of
the original BG concentration [24]. To account for this,
blood samples were collected into tubes containing the
glycolysis inhibitor NaF, which ensured that the samples
could be stored at room temperature (15 - 25 C°) for up
to24hours[25].Sincemedicationssuchasnovaminsul-
fone and ascorbic acid in concentrations of >0.4 g/L as
well as α-Methyldopa at a concentration of >0.2 g/L can
causeadecreaseoftheBGlevelbyupto50%[26],these
kinds of medication had to be documented by the GPs.
Although there is an ongoing controversy regarding the
importance of measuring BG in the fasting state or not,
instudiesconcerningthediagnosisofMetSynfastingBG
is usually measured to comply with the NCEP and WHO
definitions. To date, we are aware of only one study that
used random BG measures to study MetSyn [27]. How-
ever, it is generally known that the need for patients to
be fasting complicates study procedures and logistics
and can potentially reduce the recruitment rate. In addi-
tion, it is not possible to reliably control the fasting state
as patients might not declare snacks and caloric drinks
because they are unaware that these also influence the
BG concentration. As a result, BG levels are often spuri-
ously considered fasting and are misinterpreted. Thus,
thehighlogisticandtemporaleffortsnecessarytoobtain
fasting blood samples in epidemiologic studies involving
a large study population renders them less suitable for
opportunistic case findings in primary care.
Incontrast,randomBGtestinghasbeenproposedasthe
most efficient method for use in an integrated screening
program in such cases [28]. Due to the recruitment
strategyinthisstudy,patientswerenotnecessarilyfasting
when they came to their appointments. Thus, relatively
few fasting BG or triglyceride samples were obtained
(20%). The majority of fasting blood samples available
were those taken from subjects scheduled for follow-up
appointments for this purpose. As it was expected that
atleast40%ofpatientswouldnotkeepasecondappoint-
ment, which would result in an increase of the required
studypopulationsizeandcosts,thestudywasspecifically
designed to only schedule a second visit for a subgroup
of patients (if their non-fasting BG was 5.56 to 11.11
mmol/L or triglycerides were >1.71 mmol/L, or those
subjects in the “sample” recruitment group). This step-
wise strategy enabled a targeted collection of fasting
samples, which reduced the burden and complexities
associated with obtaining fasting data and streamlined
the study design.
Furthermore, those subjects requiring a follow-up visit
were told that their findings were ambiguous and that
the second blood sample was necessary to clarify their
diabetic status. By formulating the request for a second
visit in this way, compliance for the follow-up visit was
improved as the patients had a genuine concern about
their own health status.
In contrast to glucose, the fasting state for blood trigly-
ceride determination is not specified in the definitions
for MetSyn diagnosis, although it can be argued that it
shouldalsoideallybedoneunderfastingconditions.The
high individual variance of the blood triglyceride concen-
tration is mainly influenced by the time and way of food
intake prior to having the blood sample taken, and a
fasting period of 10-14 hours considerably reduces the
variability of serum triglycerides [29]. However, other
factors such as age, sex, circadian rhythm, physical
activity, smoking, alcohol consumption, and state of dis-
easealsohaveaninfluenceonbloodtriglycerideconcen-
tration. Random effect model estimates from approxi-
mately30differentstudiespublishedbetween1970and
1992haveshownthebiologicalvariabilityoftotalcholes-
terol to be 6%, of HDL to be 7.4%, of LDL to be 9.5%, and
of triglycerides to be 22.6% [30].
It is thus astonishing that none of the MetSyn definitions
available state the time period for fasting that is con-
sidered to be sufficient to yield serum glucose and trigly-
ceride values that are unaffected by previous caloric in-
take. There is no discussion in the literature as to
whether an 8 hour fast is sufficient, or if a 10, 12 or 14
hourfastisrequiredtoachievepreciseandreliablevalues
for the diagnosis of the MetSyn.
Limitations of this study include the potential lack of
representativeness of the sites and the population
screened. The response rate of 15% of the invited sites
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situation. However, selection of the study sites was ran-
domized and stratified by region to avoid a geographical
bias. The proportion of participating sites was similar
within the different postal code areas (Table 2). Regional
differencesintheGPparticipationratecouldbetheeffect
of random variation. The sample of GPs participating in
the study was a good representation of the total set of
GPs in Germany with respect to gender, age and the
proportionofnon-specializedinternists.Thelowresponse
rate could be the result of the recruitment process with
one single contact (mail to GP), the very short time given
forresponse(2weeks)andthestrictlimitationtoconduct
the study on one given day.
This study could not obtain data for the population of in-
dividualswhodidnotvisitapractitionerduringtherecruit-
ment period. Germany has a publicly funded health care
system for physician services with almost no user fees
(except €10 for all visits in one given quarter). Thus, ac-
cess to primary care physicians is not hindered by finan-
cial obstacles. According to Grabka and co-workers [31],
the introduction of fees did not have an effect of discrim-
inating persons of low social status or changing the
preference to visit the physician in certain months more
than in others, but instead had the beneficial effect of
reducing redundant physician visits.
There may be doubts as to whether patients attending
theirphysicianarerepresentativeofthewholepopulation.
Some patients meeting MetSyn criteria might avoid at-
tendingtheirphysicianbecausethey arein denial,in this
case an underestimation of the prevalence would have
been occurred. On the other hand, the estimated preva-
lence might be too high because the healthy population
does not routinely visit their physician, although this
problem was partially eliminated by excluding sites spe-
cializedincardiologyand/ordiabetes.However,according
to Kohler and Ziese [32], 91.8% of the adult persons in
Germany consult a general practitioner during one year.
Systematic non-response of patients could also lead to
biased results. According to the physicians’ documenta-
tion of eligible patients on the respective survey day, the
number of non-responders was 6539 compared to
35,869 responders, which would indicate a response
rateof84.6%.Thisiswellcomparablei.e.withthenation-
wide Second Dutch National Survey of General Practice
with a response rate of 76.5% for the census and 64.5%
for the health interview, yielding an age and gender dis-
tribution similar to the Dutch population [33]. Since we
assessed core information of the non-responders (e.g.
age group, gender, reason for visit), we were further able
to analyze the potential bias caused by non-response in
more detail.
In conclusion,this studywas designedto provide dataas
robust as possible within the confines of an
epidemiological study. The design and methodology en-
abled the collection of good quality data from 35,869
patientsat1511primaryhealthcarepracticesthroughout
Germany within a 2-week period. In this regard the study
strategy was highly successful and the data collected
have the potential to provide some of the first detailed
information on the prevalence of MetSyn in adults in
Germany attending a general practitioner.
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